Post Categories
It’s Going Around — Biotechs Bet on Circular RNA’s Therapeutic Potential
January 15, 2024
RNA-based vaccines have achieved superstar status and Nobel Prize recognition. Now, several biotechnology firms are considering circular RNAs (circRNAs) as a platform for therapeutic…
Tiny Biobots Have Potential to Heal Damaged Brain Cells
January 10, 2024
When you think of lab-made biological robots, you might picture something out of a horrifying science fiction novel, but a team of researchers is…
Feline Folly: Scottish Wildcats Face Extinction After Interbreeding with Domestic Cats
January 8, 2024
In Scotland, the European wildcat, which is about 20% bigger than domestic cats, with denser fur and a thick, blunt tail, is a symbol…
Gene Therapy for Muscular Dystrophy and Obesity
December 13, 2023
Gene therapy offers hope for treating a wide range of inherited and acquired diseases and conditions, ranging from muscular dystrophy to obesity. Gene therapy…
Gene Therapy for Hemophilia
December 8, 2023
Hemophilia is a rare genetic blood disorder characterized by the absence or malfunction of blood clotting factors, which can lead to severe and sometimes…
Serving Up Insects as a Sustainable Protein Alternative
December 5, 2023
As Earth’s growing population strains farmers’ capacity to produce high-quality protein sources and expanding livestock production threatens the environment, edible insects are emerging as…
Across Global Vaccine Research and Development, Recombinant Technology Takes the Lead
November 20, 2023
The COVID-19 pandemic has highlighted the importance of vaccines in protecting public health. This blog provides an overview of current vaccine research and development…
Gene Therapy for Blood Cancer
November 15, 2023
Blood cancers like leukemia and lymphoma are caused by mutations in the DNA of blood cells. These mutations cause normal blood cells to change into…
PF4 Offers Hope for Rejuvenating Aging Brains and Combatting Cognitive Decline
November 13, 2023
Three separate research studies point to a small protein, platelet-derived chemokine platelet factor 4 (PF4), as a possible tool for combating cognitive decline in…
Gene Therapy for Ocular Disease
November 8, 2023
Gene therapy for ocular disease is a rapidly evolving field with promise as a treatment option for various genetic and acquired eye diseases. It…
The Buzz on Genetically Modified Mosquitoes vs Malaria
November 6, 2023
Malaria has been a devastating disease throughout history, claiming between 150 to 300 million lives in the 20th century alone. Despite significant progress in…
Messenger RNA Delivery by Lipid Nanoparticles (LNPs)
November 1, 2023
What are they? Lipid nanoparticles (LNPs) are a crucial component in the delivery of RNA drugs, including mRNA-based therapeutics and small interfering RNA (siRNA)…
New Antibiotic Could Simplify Gonorrhea Treatment
November 20, 2024
Gonorrhea is one of the most widespread sexually transmitted infections, with as many as 82 million new infections occurring worldwide each year. While not…
Promising Clinical Trial Results Suggest a Path Forward in Treating DMD
November 18, 2024
Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming from mutations in the gene that encodes the protein dystrophin, weakens muscles and…
Early Alzheimer’s Patients Benefit from Leqembi
November 13, 2024
Like many neurodegenerative diseases, early diagnosis and treatment of Alzheimer’s disease (AD) can greatly improve quality of life for individuals with the disease. Now,…
Sounding Out Disease: Using AI to Help Close the Diagnosis Gap for Millions with Tuberculosis
November 11, 2024
With millions of tuberculosis (TB) cases left undiagnosed each year due to limited healthcare access or incorrect diagnoses, researchers are turning to artificial intelligence…
Rezdiffra Gains Approval, Marks a New Chapter in Treating NASH (MASH) with Liver Scarring
November 4, 2024
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom), the first medication for treating patients with nonalcoholic steatohepatitis (NASH) with moderate to…
Exciting New Epilepsy Drug Reduces Seizures
October 30, 2024
Epilepsy affects as many as 50 million people worldwide, with a broad range of disease subtypes with limited treatment options. Fortunately, a new epilepsy…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
